ArticleJournal of managed care & specialty pharmacy2017
Letter--Corrected Net Health Benefit Calculations for Enzalutamide Using ASCO Value Framework Guidelines and NCCN Evidence Blocks.
Scott Flanders et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.